Fulgent Genetics (NASDAQ:FLGT) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Earnings
Fulgent Genetics beat estimated earnings by 33.33%, reporting an EPS of $3.48 versus an estimate of $2.61.
Revenue was up $43.31 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.8 which was followed by a 1.08% increase in the share price the next day.
Here's a look at Fulgent Genetics's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | 3.25 | 2.81 | 5.86 | 4.05 |
| EPS Actual | 4.05 | 2.55 | 6.59 | 6.20 |
| Revenue Estimate | 264.00M | 197.34M | 321.51M | 199.44M |
| Revenue Actual | 227.87M | 153.62M | 359.43M | 294.98M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
